{"organizations": [], "uuid": "09f2f72a09eb6865c4d0828480a0578286a4828a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/31/business-wire-taro-to-announce-third-quarter-results-on-february-7-2018.html", "country": "US", "domain_rank": 767, "title": "Taro to Announce Third Quarter Results on February 7, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.896, "site_type": "news", "published": "2018-02-01T01:21:00.000+02:00", "replies_count": 0, "uuid": "09f2f72a09eb6865c4d0828480a0578286a4828a"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/31/business-wire-taro-to-announce-third-quarter-results-on-february-7-2018.html", "ord_in_thread": 0, "title": "Taro to Announce Third Quarter Results on February 7, 2018", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7, 2018.\nThe release will be accessible on Taro’s website at www.taro.com .\nAbout Taro\nTaro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com .\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180131006331/en/\nTaro Pharmaceutical Industries Ltd.\nMariano Balaguer\nVP, Chief Financial Officer\n914-345-9001\nMariano.Balaguer@Taro.com\nor\nWilliam J. Coote\nAVP, Business Finance, Treasurer and Investor Relations\n914-345-9001\nWilliam.Coote@Taro.com\nSource: Taro Pharmaceutical Industries Ltd.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51751704&newsitemid=20180131006331&lan=en-US&anchor=www.taro.com&index=2&md5=0ef5820076bab05e70374e18018bca21", "http://www.businesswire.com/news/home/20180131006331/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.taro.com&esheet=51751704&newsitemid=20180131006331&lan=en-US&anchor=www.taro.com&index=1&md5=f11bda7993a1aaae603666a90f51948c"], "published": "2018-02-01T01:21:00.000+02:00", "crawled": "2018-02-01T01:58:36.006+02:00", "highlightTitle": ""}